Antepartum fetal surveillance

International Journal of Gynecology and Obstetrics

Volumn 68, Issue 2, 2000, Pages 175-186

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001238621     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0020-7292(00)80016-8     Document Type: Article

References (62)

1. Boddy K, Dawes GS, Fisher R, Pinter S, Robinson JS. Foetal respiratory movements, electrocortical and cardiovascular responses to hypoxaemia and hypercapnia in sheep. J Physiol 1974;243:599-618 (Level III)
2. Manning FA, Platt LD. Maternal hypoxemia and fetal breathing movements. Obstet Gynecol 1979;53:758-760 (Level III)
3. Murata Y, Martin CB Jr, Ikenoue T, Hashimoto T, Taira S, Sagawa T, et al. Fetal heart rate accelerations and late decelerations during the course of intrauterine death in chronically catheterized rhesus monkeys. Am J Obstet Gynecol 1982;144:218-223 (Level III)
4. Natale R, Clewlow F, Dawes GS. Measurement of fetal forelimb movements in the lamb in utero. Am J Obstet Gynecol 1981;140:545-551 (Level III)
5. Seeds AE. Current concepts of amniotic fluid dynamics. Am J Obstet Gynecol 1980;138:575-586 (Level III)
6. Weiner CP, Sipes SL, Wenstrom K. The effect of fetal age upon normal fetal laboratory values and venous pressure. Obstet Gynecol 1992;79:713-718 (Level III)
7. Manning FA, Snijders R, Harman CR, Nicolaides K, Menticoglou S, Morrison I. Fetal biophysical profile score. VI. Correlation with antepartum umbilical venous fetal pH. Am J Obstet Gynecol 1993;169:755-763 (Level II-2)
8. Pearson JF, Weaver JB. Fetal activity and fetal wellbeing: an evaluation. BMJ 1976;1(6021):1305-1307 (Level III)
9. Moore TR, Piacquadio K. A prospective evaluation of fetal movement screening to reduce the incidence of antepartum fetal death. Am J Obstet Gynecol 1989;160:1075-1080 (Level II-2)
10. Neldam S. Fetal movements as an indicator of fetal well-being. Dan Med Bull 1983;30:274-278 (Level II-1)
11. Huddleston JF, Sutliff G, Robinson D. Contraction stress test by intermittent nipple stimulation. Obstet Gynecol 1984;63:669-673 (Level II-3)
12. Freeman RK. The use of the oxytocin challenge test for antepartum clinical evaluation of uteroplacental respiratory function. Am J Obstet Gynecol 1975;121:481-489 (Level III)
13. Freeman RK, Anderson G, Dorchester W. A prospective multi-institutional study of antepartum fetal heart rate monitoring. I. Risk of perinatal mortality and morbidity according to antepartum fetal heart rate test results. Am J Obstet Gynecol 1982;143:771-777 (Level II-3)
14. Graca LM, Cardoso CG, Clode N, Calhaz-Jorge C. Acute effects of maternal cigarette smoking on fetal heart rate and fetal body movements felt by the mother. J Perinat Med 1991;19:385-390 (Level III)
15. Clark SL, Sabey P, Jolley K. Nonstress testing with acoustic stimulation and amniotic fluid volume assessment: 5973 tests without unexpected fetal death. Am J Obstet Gynecol 1989;160:694-697 (Level II-3)
16. Miller DA, Rabello YA, Paul RH. The modified biophysical profile: antepartum testing in the 1990s. Am J Obstet Gynecol 1996;174:812-817 (Level II-3)
17. Smith CV, Phelan JP, Platt LD, Broussard P, Paul RH. Fetal acoustic stimulation testing. II. A randomized clinical comparison with the nonstress test. Am J Obstet Gynecol 1986;155:131-134 (Level I)
18. Evertson LR, Gauthier RJ, Schifrin BS, Paul RH. Antepartum fetal heart rate testing. I. Evolution of the nonstress test. Am J Obstet Gynecol 1979;133:29-33 (Level II-3)
19. Bishop EH. Fetal acceleration test. Am J Obstet Gynecol 1981;141:905-909 (Level II-2)
20. Lavin JP Jr, Miodovnik M, Barden TP. Relationship of nonstress test reactivity and gestational age. Obstet Gynecol 1984;63;338-344 (Level II-3)
21. Druzin ML, Fox A, Kogut E, Carlson C. The relationship of the nonstress test to gestational age. Am J Obstet Gynecol 1985;153:386-389 (Level III)
22. Meis PJ, Ureda JR. Swain M, Kelly RT, Penry M, Sharp P. Variable decelerations during nonstress tests are not a sign of fetal compromise. Am J Obstet Gynecol 1986;154:586-590 (Level II-3)
23. Anyaegbunam A, Brustman L, Divon M, Langer O. The significance of antepartum variable decelerations. Am J Obstet Gynecol 1986;155:707-710 (Level II-2)
24. O'Leary JA, Andrinopoulos GC, Giordano PC. Variable decelerations and the nonstress test: an indication of cord compromise. Am J Obstet Gynecol 1980;137:704-706 (Level III)
25. Bourgeois FJ, Thiagarajah S, Harbert GM Jr. The significance of fetal heart rate decelerations during nonstress testing. Am J Obstet Gynecol 1984;150:213-216 (Level III)
26. Druzin ML, Gratacos J, Keegan KA, Paul RH. Antepartum fetal heart rate testing. VII. The significance of fetal bradycardia. Am J Obstet Gynecol 1981;139:194-198 (Level III)
27. Pazos R, Vuolo K, Aladjem S, Lueck J, Anderson C. Association of spontaneous fetal heart rate decelerations during antepartum nonstress testing and intrauterine growth retardation. Am J Obstet Gynecol 1982;144:574-577 (Level II-2)
28. Manning FA, Morrison I, Lange IR, Harman CR, Chamberlain PF. Fetal biophysical profile scoring: selective use of the nonstress test. Am J Obstet Gynecol 1987;156:709-712 (Level II-3)
29. Chamberlain PF, Manning FA, Morrison I, Harman CR, Lange IR. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol 1984;150:245-249 (Level II-3)
30. Manning FA, Harman CR, Morrison I, Menticoglou SM, Lange IR, Johnson JM. Fetal assessment based on fetal biophysical profile scoring. IV. An analysis of perinatal morbidity and mortality. Am J Obstet Gynecol 1990;162:703-709 (Level II-3)
31. Rutherford SE, Phelan JP, Smith CV, Jacobs N. The four-quadrant assessment of amniotic fluid volume: an adjunct to antepartum fetal heart rate testing. Obstet Gynecol 1987;70:353-356 (Level III)
32. Erskine RL, Ritchie JW. Umbilical artery blood flow characteristics in normal and growth-retarded fetuses. Br J Obstet Gynaecol 1985;92:605-610 (Level II-2)
33. Gudmundsson S, Marsal K. Umbilical and uteroplacental blood flow velocity waveforms in pregnancies with fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1988;27:187-196 (Level III)
34. Reuwer PJ, Bruinse HW, Stoutenbeek P, Has AA. Doppler assessment of the fetoplacental circulation normal and growth-retarded fetuses. Eur J Obstet Gynecol Reprod Biol 1984;18:199-205 (Level II-2)
35. Karsdorp VH, van Vugt JM, van Geijn HP, Kostense PJ, Arduini D, Montenegra N, et al. Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet 1994;344:1664-1668 (Level II-2)
36. Giles WB, Trudinger BJ, Baird PJ. Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation. Br J Obstet Gynaecol 1985;92:31-38 (Level II-2)
37. Nicolaides KH, Bilardo CM, Soothill PW, Campbell S. Absence of end diastolic frequencies in umbilical artery: a sign of fetal hypoxia and acidosis. BMJ 1988;297:1026-1027 (Level III)
38. Almstrom H, Axelsson O, Cnattingius S, Ekman G, Maesel A, Ulmsten U, et al. Comparison of umbilicalartery velocimetry and cardiotocography for surveillance of small-for-gestational-age fetuses. Lancet 1992;340:936-940 (Level I )
39. Johnstone FD, Prescott R, Hoskins P, Greer IA, McGlew T, Compton M. The effect of introduction of umbilical Doppler recordings to obstetric practice. Br J Obstet Gynaecol 1993;100:733-741 (Level I)
40. Newnham JP, O'Dea MR, Reid KP, Diepeveen DA. Doppler flow velocity waveform analysis in high risk pregnancies: a randomized controlled trial. Br J Obstet Gynaecol 1991;98:956-963 (Level I)
41. Omtzigt AM, Reuwer PJ, Bruinse HW. A randomized controlled trial on the clinical value of umbilical Doppler velocimetry in antenatal care. Am J Obstet Gynecol 1994;170:625-634 (Level I)
42. Pattinson RC, Norman K, Odendaal HJ. The role of Doppler velocimetry in the management of high risk pregnancies. Br J Obstet Gynaecol 1994;101:114-120 (Level I)
43. Trudinger BJ, Cook CM, Giles WB, Connelly A, Thompson RS. Umbilical artery flow velocity waveforms in high-risk pregnancy. Randomised controlled trial. Lancet 1987;1(8526):188-190 (Level I)
44. Tyrrell SN, Lilford RJ, Macdonald HN, Nelson EJ, Porter J, Gupta JK. Randomized comparison of routine vs highly selective use of Doppler ultrasound and biophysical scoring to investigate high risk pregnancies. Br J Obstet Gynaecol 1990;97:909-916 (Level I)
45. Thacker SB, Berkelman RL. Assessing the diagnostic accuracy and efficacy of selected antepartum fetal surveillance techniques. Obstet Gynecol Surv 1986;41:121-141 (Level III)
46. Enkin M, Keirse MJNC, Renfrew M, Neilson J. A guide to effective care in pregnancy and childbirth. 2nd ed. Oxford: Oxford University Press, 1995:410 (Level III)
47. Nageotte MP, Towers CV, Asrat T, Freeman RK. Perinatal outcome with the modified biophysical profile. Am J Obstet Gynecol 1994;170:1672-1676 (Level I)
48. Rouse DJ, Owen J, Goldenberg RL, Cliver SP. Determinants of the optimal time in gestation to initiate antenatal fetal testing: a decision-analytic approach. Am J Obstet Gynecol 1995;173:1357-1363 (Decision Analysis)
49. Lagrew DC, Pircon RA, Towers CV, Dorchester W, Freeman RK. Antepartum fetal surveillance in patients with diabetes: when to start? Am J Obstet Gynecol 1993;168:1820-1826 (Level III)
50. Pircon RA, Lagrew DC. Towers CV, Dorchester WL, Gocke SE, Freeman RK. Antepartum testing in the hypertensive patient: when to begin. Am J Obstet Gynecol 1991;164:1563-1570 (Level III)
51. Manning FA, Morrison I, Harman CR, Lange IR, Menticoglou S. Fetal assessment based on fetal biophysical profile scoring: experience in 19,221 referred high-risk pregnancies. II. An analysis of false-negative fetal deaths. Am J Obstet Gynecol 1987;157:880-884 (Level II-3)
52. Staisch KJ, Westlake JR, Bashore RA. Blind oxytocin challenge test and perinatal outcome. Am J Obstet Gynecol 1980;138:399-403 (Level II-2)
53. Garite TJ, Linzey EM, Freeman RK, Dorchester W. Fetal heart rate patterns and fetal distress in fetuses with congenital anomalies. Obstet Gynecol 1979;53:716-720 (Level II-2)
54. Leveno KJ, Quirk JG Jr, Cunningham FG, Nelson SD, Santos-Ramos R, Toofanian A, et al. Prolonged pregnancy. I. Observations concerning the causes of fetal distress. Am J Obstet Gynecol 1984;150:465-473 (Level III)
55. Phelan JP, Platt LD, Yeh SY, Broussard P, Paul RH. The role of ultrasound assessment of amniotic fluid volume in the management of the postdate pregnancy. Am J Obstet Gynecol 1985;151:304-308 (Level II-2)
56. Haley J, Tuffnell DJ, Johnson N. Randomised controlled trial of cardiotocography versus umbilical artery Doppler in the management of small for gestational age fetuses. Br J Obstet Gynaecol 1997;104:431-435 (Level I)
57. Nienhuis SJ, Vles JS, Gerver WJ, Hoogland HJ. Doppler ultrasonography in suspected intrauterine growth retardation: a randomized clinical trial. Ultrasound Obstet Gynecol 1997;9:6-13 (Level I)
58. Neilson JP, Alfirevic Z. Doppler ultrasound for fetal assessment in high risk pregnancies (Cochrane Review). In: The Cochrane Library, Issue 3, 1999. Oxford: Update Software (Meta-analysis)
59. Mason GC, Lilford RJ, Porter J, Nelson E, Tyrell S. Randomised comparison of routine versus highly selective use of Doppler ultrasound in low risk pregnancies. Br J Obstet Gynaecol 1993;100:130-133 (Level I)
60. Mari G, Deter RL. Middle cerebral artery flow velocity waveforms in normal and small-for-gestational-age fetuses. Am J Obstet Gynecol 1992;166:1262-1270 (Level II-2)
61. Ott WJ, Mora G, Arias F, Sunderji S, Sheldon G. Comparison of the modified biophysical profile to a "new" biophysical profile incorporating the middle cerebral artery to umbilical artery velocity flow systolic/diastolic ratio. Am J Obstet Gynecol 1998;178:1346-1353 (Level I)
62. Grant A, Elbourne D, Valentin L, Alexander S. Routine formal fetal movement counting and risk of antepartum late death in normally formed singletons. Lancet 1989;2(8659):345-349 (Level I)